Brooklyn Immunotherapeutics Inc
Change company Symbol lookup
Select an option...
BTX Brooklyn Immunotherapeutics Inc
SBCF Seacoast Banking Corporation of Florida
MSSAU Metal Sky Star Acquisition Corp
SDGR Schrodinger Inc
GPC Genuine Parts Co
VENA Venus Acquisition Corp
VECO Veeco Instruments Inc
IGTAU Inception Growth Acquisition Ltd
BAC-K Bank of America Corp
FAX abrdn Asia-Pacific Income Fund Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Brooklyn ImmunoTherapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing cytokine-based therapies for treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Its lead product candidate, IRX-2, is a cytokine therapy, to treat patients with head and neck cancer. IRX-2 is a mixed, human-derived cytokine product with multiple active constituents including Interleukin-2 (IL2) and other key cytokines, which restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. The Company also has multiple cell and gene-editing therapies in preclinical development for various indications, including acute respiratory distress syndrome, solid tumor indications, as well as in vivo gene-editing therapies for rare genetic diseases. Its subsidiaries include Brooklyn ImmunoTherapeutics LLC, Novellus, Inc. and Novellus Therapeutics, Ltd.

Closing Price
$0.2303
Day's Change
-0.0319 (-12.17%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2993
Day's Low
0.2303
Volume
(Heavy Day)
Volume:
1,727,500

10-day average volume:
815,612
1,727,500

SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of U.S. Bancorp (USB) and Encourages Investors to Contact the Firm

12:15 pm ET August 2, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / August 2, 2022 / Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating claims of violations of federal securities laws on behalf of investors of U.S. Bancorp ("U.S. Bancorp" or the "Company") (NYSE:USB).

The investigation concerns whether U.S. Bancorp and certain of its officers and directors have engaged in violation of securities laws and/or other business practices. The conduct pertains to U.S. Bancorp's penalty issued by the Consumer Financial Protection Bureau ("CFPB").

On May 4, 2021, the Company announced an investigation by the CFPB into its sales practices. Upon this news, shares of U.S. Bancorp dropped precipitously.

On July 29, 2022, U.S. Bancorp was fined by CFPB for illegally accessing its customers' credit reports and opening checking and savings accounts, credit cards, and lines of credit without customers' permission. On this news, shares fell 4%, closing at $46.12 on July 29, 2022.

If you suffered loss in U.S. Bancorp and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys at (914) 733-7256 or via email at agreco@lowey.com or afarah@lowey.com.

Whistleblowers: Persons with non-public information regarding U.S. Bancorp should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.

44 South Broadway, Suite 1100

White Plains, NY 10601

Tel: (914) 733-7256

Email: agreco@lowey.com

afarah@lowey.com

SOURCE: Lowey Dannenberg





View source version on accesswire.com:

https://www.accesswire.com/710573/SHAREHOLDER-ALERT-Lowey-Dannenberg-PC-Investigates-Claims-on-Behalf-of-Investors-of-US-Bancorp-USB-and-Encourages-Investors-to-Contact-the-Firm



comtex tracking

COMTEX_411430587/2457/2022-08-02T12:15:26

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.